CD8A and neoplasm: In this study, the number of both CD3+ and CD8+ TILs in the tumor center (TC), the tumor stroma (TS) and the invasive margin (IM), were counted separately, and therefore a more accurate evaluation of their relationship with clinical characteristics and outcome may be achieved, which helps for guiding personalized treatment.